Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-11-26
pubmed:abstractText
Atypical teratoid/rhabdoid tumors are malignant embryonal tumors characterized by the presence of rhabdoid cells, genetic alterations affecting the SMARCB1 gene (hSNF5/INI1), and a poor prognosis. Whether INI1 plays a role in the pathogenesis of other central nervous system tumors is uncertain. We report on cases of 2 young children with unusual intracranial nonrhabdoid neuroectodermal tumors within and around the third or fourth ventricle that are characterized by cribriform strands and trabeculae and well-defined epithelial membrane antigen-immunopositive surfaces and show INI1 protein loss. Histological and immunohistochemical features did not correspond to established tumor types, including atypical teratoid/rhabdoid tumors, medulloepithelioma, choroid plexus carcinoma, and ependymoma. Fluorescence in situ hybridization analyses failed to identify chromosomal alterations affecting the SMARCB1 locus, but sequencing revealed a homozygous 4-bp duplication in exon 4 (492duplCCTT) in one of the tumors. Both children responded well to conventional adjuvant therapy protocols and are alive and in complete remission longer than 5 years postoperatively. We suggest that cribriform neuroepithelial tumor (CRINET) is a nonrhabdoid ventricular tumor that shows loss of tumoral INI1 protein and has a relatively favorable prognosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-3069
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1249-55
pubmed:meshHeading
pubmed-meshheading:19915490-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19915490-Brain Neoplasms, pubmed-meshheading:19915490-Child, Preschool, pubmed-meshheading:19915490-Chromosomal Proteins, Non-Histone, pubmed-meshheading:19915490-Combined Modality Therapy, pubmed-meshheading:19915490-DNA-Binding Proteins, pubmed-meshheading:19915490-Female, pubmed-meshheading:19915490-Fourth Ventricle, pubmed-meshheading:19915490-Humans, pubmed-meshheading:19915490-Immunohistochemistry, pubmed-meshheading:19915490-In Situ Hybridization, Fluorescence, pubmed-meshheading:19915490-Infant, pubmed-meshheading:19915490-Male, pubmed-meshheading:19915490-Neoplasms, Neuroepithelial, pubmed-meshheading:19915490-Neurosurgical Procedures, pubmed-meshheading:19915490-Prognosis, pubmed-meshheading:19915490-Radiotherapy, pubmed-meshheading:19915490-Third Ventricle, pubmed-meshheading:19915490-Transcription Factors
pubmed:year
2009
pubmed:articleTitle
Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis.
pubmed:affiliation
Institute of Neuropathology, University Hospital Münster, Münster, Germany. hasselblatt@uni-muenster.de
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't